Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Stuart Arbuckle

Stuart Arbuckle is recorded as COO at Vertex Pharmaceuticals Inc / Ma (VRTX). The proxy statement of Vertex Pharmaceuticals Inc / Ma reports total compensation of $9,996,347 for Stuart Arbuckle in fiscal 2025, including a base salary of $521,486. Disclosed compensation is on record for 9 fiscal years. Stuart Arbuckle has spoken on 14 earnings calls across 1 company, most recently for Vertex Pharmaceuticals Inc / Ma on February 10, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Vertex Pharmaceuticals Inc / Ma

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Vertex Pharmaceuticals Inc / Ma (VRTX) $521,486 $9,996,347
2024 Vertex Pharmaceuticals Inc / Ma (VRTX) $941,154 $9,383,463
2023 Vertex Pharmaceuticals Inc / Ma (VRTX) $900,000 $8,998,949
2022 Vertex Pharmaceuticals Inc / Ma (VRTX) $900,000 $14,999,106
2021 Vertex Pharmaceuticals Inc / Ma (VRTX) $842,308 $7,810,141
2020 Vertex Pharmaceuticals Inc / Ma (VRTX) $830,769 $7,282,978
2019 Vertex Pharmaceuticals Inc / Ma (VRTX) $770,962 $6,859,533
2018 Vertex Pharmaceuticals Inc / Ma (VRTX) $721,923 $5,347,092
2017 Vertex Pharmaceuticals Inc / Ma (VRTX) $700,000 $4,400,633

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 2 earlier activities